Loading...You are here: Home > 'allogeneic T-cell immunotherapy'
Atara CEO departing, company pivots toward new leadership
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.